These novel observations provide mechanistic insights into the induction of apoptosis by ATO in EVI-1-positive leukemia cell lines and may facilitate the development of clinical strategies to improve the therapeutic efficacy of the treatment of EVI-1-positive human cancers. Here, MECOM is linked to cancer.